Table 5.

Six-month outcomes of Siriraj Favipiravir Clinic.

Outcomes	Total (N = 732)
Favipiravir use, n (%)
Known	730 (99.7)
Complete dose of treatment	657 (90.0)
Incomplete dose of treatment	20 (2.7)
Not take the medication	46 (6.3)
Not received the medication	7 (1.0)
Unknown	2 (0.3)
Healthcare system accessibility, n (%)	343 (46.9)
Places of isolation, n (%)
Hospital	99 (13.5)
Field hospital	51 (7)
Hospitel	113 (15.4)
Community isolation	7 (1.0)
Home isolation or self-isolation	462 (63.1)
Oxygen supplement use, n (%)	52 (7.1)
Types of oxygen supplement, n (%)
Oxygen cannula	31 (59.6)
Oxygen mask	2 (3.8)
High flow nasal cannula	9 (17.3)
Endotracheal tube	5 (9.6)
Unknown	5 (9.6)
Final outcomes, n (%)
Improved	635 (86.7)
Not changed	74 (10.1)
Not improved	13 (1.8)
Death (within 30 d)	9 (1.2)
Unknown	1 (0.1)